Analgesics Market Overview in Ecuador

  • March 2014
  • -
  • Euromonitor International
  • -
  • 21 pages

The systematic analgesic sector has experienced a slowdown in sales from August to December, 2009 due to a government ban on sales. The ban is a measure to prevent AH1N1 flu cases in Ecuador. Government hopes to prevent Ecuadorians from using self-medication when experiencing flu symptoms, so they will go to a doctor and if they have AH1N1 be properly diagnosed. The prohibition was extended to advertising and the promotion of systematic analgesics.

Euromonitor International's Analgesics Products in Ecuador report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data from 2005 to 2009 , allowing you to identify the segments driving growth. Projections to 2014 illustrate how the industry is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: indsutry size (historic and projections ), market shares , brand shares and distribution channel figures .

Reasons to Buy This Report
* Gain in-depth understanding of the Consumer Health market ;
* Identify areas of growth and understand key dynamics ;
* Get a full overview of the competitive landscape , the industry ’s major players and leading brands;
* Anticipate market change with 5 year forecasts .

Euromonitor International has over 30 years experience of publishing industry research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Table Of Contents

Analgesics in Ecuador

August 2010
List of Contents and Tables
Executive Summary
Market Performance
Regulations Affect Consumer Healthcare Products
Competitive Environment
Distribution Channels
Forecast Performance
Market Indicators
Data table 1 Consumer Expenditure on Health Goods and Medical Services from 2004 to 2009
Data table 2 Life Expectancy at Birth from 2004 to 2009
Market Data
Data table 3 Sales of Consumer Health by Segment : Value from 2004 to 2009
Data table 4 Sales of Consumer Health by Segment : % Value Growth from 2004 to 2009
Data table 5 Consumer Health Market Shares by Value from 2005 to 2009
Data table 6 Consumer Health Brand Shares by Value from 2006 to 2009
Data table 7 Sales of Consumer Health by Distribution Format: % Analysis from 2004 to 2009
Data table 8 Sales of Consumer Health by Segment and Distribution Format: % Analysis 2009
Data table 9 Projection Sales of Consumer Health by Segment : Value from 2009 to 2014
Data table 10 Projection Sales of Consumer Health by Segment : % Value Growth from 2009 to 2014
Appendix
OTC Registration and Classification
Generics
Switches
Summary 1 OTC Healthcare Switches from 2007 to 2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Carvagu SA
Strategic Direction
Key Facts
Summary 3 Carvagu SA: Key Facts
Summary 4 Carvagu SA: Operational Indicators
Company Background
Production
Competitive Positioning
Grupo Farma Del Ecuador SA
Strategic Direction
Key Facts
Summary 5 GRUPO FARMA DEL ECUADOR SA: Key Facts
Summary 6 GRUPO FARMA DEL ECUADOR SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 GRUPO FARMA DEL ECUADOR SA: Competitive Position 2008
Laboratorio Farmaceutico Lamosan Cia Ltda
Strategic Direction
Key Facts
Summary 8 Laboratorio Farmaceutico Lamosan Cia Ltda: Key Facts
Company Background
Production
Competitive Positioning
Summary 9 Laboratorio Farmaceutico Lamosan Cia Ltda : Competitive Position 2008
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Data table 11 Sales of Analgesics by Subsector: Value from 2004 to 2009
Data table 12 Sales of Analgesics by Subsector: % Value Growth from 2004 to 2009
Data table 13 Analgesics Market Shares by Value from 2005 to 2009
Data table 14 Analgesics Brand Shares by Value from 2006 to 2009
Data table 15 Projection Sales of Analgesics by Subsector: Value from 2009 to 2014
Data table 16 Projection Sales of Analgesics by Subsector: % Value Growth from 2009 to 2014

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • August 2014
  • by Global Data

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • Dec 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.